Primary Record
Encorafenib
- In stock
- 2,414 g
- Purity
- 98.2 %
- CAS
- 1269440-17-6
Compound Identifiers & Properties
- CAS
- 1269440-17-6
- PubChem CID
- 50922675
- SMILES
- C[C@@H](CNC1=NC=CC(=N1)C2=CN(N=C2C3=C(C(=CC(=C3)Cl)NS(=O)(=O)C)F)C(C)C)NC(=O)OC
- Canonical SMILES
- COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1
Names & Synonyms
- Encorafenib
- LGX818
- Braftovi
- 1269440-17-6
- encorafenibum
- LGX-818
- (R)-Encorafenib
- Braftovi (TN)
- NVP-LGX818
- NVP-LGX818-NXA
- LGX 818
- Encorafenib (LGX818)
- Encorafenib (Standard)
- NVP-LGX-818-NXA
- Encorafenib [USAN:INN]
- RefChem:58132
- ENCORAFENIB [MI]
- Encorafenib(LGX-818)
- LGX-818(Encorafenib)
- ENCORAFENIB [INN]
- ENCORAFENIB [JAN]
- ENCORAFENIB [USAN]
- D0TK7R
- LGX-818(Encorafenib)?
- UNII-8L7891MRB6
- C22H27ClFN7O4S
- 8L7891MRB6
- Encorafenib Refrence standard
- ENCORAFENIB [WHO-DD]
- DTXSID00155347
- Encorafenib (JAN/USAN/INN)
- MFCD25976758
- GTPL7908
- orb1300725
- SCHEMBL8228295
- CHEMBL3301612
- DTXCID7077838
- SCHEMBL29368575
- ENCORAFENIB [ORANGE BOOK]
- L01XE46
- CMJCXYNUCSMDBY-ZDUSSCGKSA-N
- BDBM221688
- GLXC-10822
- BCP08458
- EX-A1587
- EBC-17146
- HY-15605R
- NSC778304
- NSC800093
- s7108
- ZINC68249103
- AKOS027254498
- CCG-269960
- CS-2289
- DB11718
- FC65061
- NSC-778304
- NSC-800093
- NCGC00378599-03
- AC-30230
- AS-35201
- HY-15605
- B1174
- NS00072923
- Carbamic acid, N-[(1S)-2-[[4-[3-[5-chloro-2-fluoro-3-[(methylsulfonyl)amino]phenyl]-1-(1-methylethyl)-1H-pyrazol-4-yl]-2-pyrimidinyl]amino]-1-methylethyl]-, methyl ester
- J3.371.287A
- A13226
- D11053
- US9314464, 9
- A855937
- EN300-24699278
- methyl N-[(2S)-1-[[4-[3-[5-chloro-2-fluoro-3-(methanesulfonamido)phenyl]-1-propan-2-ylpyrazol-4-yl]pyrimidin-2-yl]amino]propan-2-yl]carbamate
- Q15409405
- B0084-462563
- (S)-Methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate
- Methyl N-[(2S)-1-({4-[3-(5-chloro-2-fluoro-3-methanesulfonamidophenyl)-1-(propan-2-yl)-1H-pyrazol-4-yl]pyrimidin-2-yl}amino)propan-2-yl]carbamate
- 1269440-29-0
- (S)-Methyl [1-[[4-[3-[5-chloro-2-fluoro-3-(methylsulfonamido)phenyl]-1-isopropyl-1H-pyrazol-4-yl]pyrimidin-2-yl]amino]propan-2-yl]carbamate
- (S)-Methyl 1-(4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-ylamino)propan-2-ylcarbamate
- [(1S)-1-Methyl-2-(4-(1-isopropyl-3-(2-fluoro-3-methanesulfonylamino-5-chlorophenyl)-1H-pyrazole-4-yl)2-pyrimidinylamino)ethyl]carbamic acid methyl ester
- 1269440-69-8
- CARBAMIC ACID, N-((1S)-2-((4-(3-(5-CHLORO-2-FLUORO-3-((METHYLSULFONYL)AMINO)PHENYL)-1-(1-METHYLETHYL)-1H-PYRAZOL-4-YL)-2-PYRIMIDINYL)AMINO)-1-METHYLETHYL)-, METHYL ESTER
- Methyl {(2S)-1-[(4-{3-[5-chloro-2-fluoro-3-(methanesulfonamido)phenyl]-1-(propan-2-yl)-1H-pyrazol-4-yl}pyrimidin-2-yl)amino]propan-2-yl}carbamate
- METHYL N-((2S)-1-((4-(3-(5-CHLORO-2-FLUORO-3-(METHANESULFONAMIDO)PHENYL)(-1-(PROPAN-2-YL)-1H-PYRAZOL-4-YL(PYRIMIDIN-2-YL)AMINO)PROPAN-2-YL)CARBAMATE
- methyl N-((2S)-1-((4-(3-(5-chloro-2-fluoro-3-(methanesulfonamido)phenyl)-1-propan-2-ylpyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate
- methyl N-((2S)-1-((4-(3-(5-chloro-2-fluoro-3-methanesulfonamidophenyl)-1-(propan-2-yl)-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate
- methyl N-[(1S)-2-[[4-[3-[5-chloro-2-fluoro-3-(methanesulfonamido)phenyl]-1-isopropyl-pyrazol-4-yl]pyrimidin-2-yl]amino]-1-methyl-ethyl]carbamate
- N-[(1S)-2-[[4-[3-[5-Chloro-2-fluoro-3-[(methylsulfonyl)amino]phenyl]-1-(1-methylethyl)-1H-pyrazol-4-yl]-2-pyrimidinyl]am ino]-1-methylethyl]-carbamic acid methyl ester
- N-[(1S)-2-[[4-[3-[5-Chloro-2-fluoro-3-[(methylsulfonyl)amino]phenyl]-1-(1-methylethyl)-1H-pyrazol-4-yl]-2-pyrimidinyl]amino]-1-methylethyl]-carbamic Acid Methyl Ester; (S)-Methyl [1-[[4-[3-[5-chloro-2-fluoro-3-(methylsulfonamido)phenyl]-1-isopropyl-1H-pyrazol-4-yl]pyrimidin-2-yl]amino]propan-2-yl]carbamate
- tert-butyl 5-chloro-2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylcarbamate: